Jane Street’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-96,746
| Closed | -$1.35M | – | 7783 |
|
|
2020
Q1 | $689K | Buy |
96,746
+46,474
| +92% | +$580K | ﹤0.01% | 3272 |
|
|
2019
Q4 | $1.2M | Buy |
50,272
+28,117
| +127% | +$776K | ﹤0.01% | 2534 |
|
|
2019
Q3 | $595K | Buy |
22,155
+10,129
| +84% | +$284K | ﹤0.01% | 3325 |
|
|
2019
Q2 | $326K | Sell |
12,026
-51,066
| -81% | -$1.6M | ﹤0.01% | 4093 |
|
|
2019
Q1 | $2.19M | Buy |
63,092
+28,021
| +80% | +$809K | ﹤0.01% | 1932 |
|
|
2018
Q4 | $684K | Buy |
35,071
+26,641
| +316% | +$548K | ﹤0.01% | 3070 |
|
|
2018
Q3 | $224K | Sell |
8,430
-2,433
| -22% | -$79.4K | ﹤0.01% | 4562 |
|
|
2018
Q2 | $410K | Buy |
10,863
+137
| +1% | +$5.24K | ﹤0.01% | 3808 |
|
|
2018
Q1 | $350K | Buy |
10,726
+2,957
| +38% | +$130K | ﹤0.01% | 3859 |
|
|
2017
Q4 | $378K | Sell |
7,769
-18,802
| -71% | -$951K | ﹤0.01% | 3505 |
|
|
2017
Q3 | $1.44M | Sell |
26,571
-19,918
| -43% | -$1.17M | ﹤0.01% | 1925 |
|
|
2017
Q2 | $2.61M | Buy |
46,489
+41,127
| +767% | +$1.65M | 0.01% | 1249 |
|
|
2017
Q1 | $210K | Buy |
+5,362
| New | +$171K | ﹤0.01% | 3820 |
|
|
2016
Q4 | – | Sell |
-10,620
| Closed | -$207K | – | 4832 |
|
|
2016
Q3 | $241K | Sell |
10,620
-1,233
| -10% | -$28.9K | ﹤0.01% | 3515 |
|
|
2016
Q2 | $280K | Sell |
11,853
-15,764
| -57% | -$389K | ﹤0.01% | 3405 |
|
|
2016
Q1 | $563K | Buy |
27,617
+13,491
| +96% | +$428K | ﹤0.01% | 2471 |
|
|
2015
Q4 | $727K | Buy |
+14,126
| New | +$685K | ﹤0.01% | 2088 |
|
|
2014
Q3 | – | Sell |
-51,418
| Closed | -$1.5M | – | 3268 |
|
|
2014
Q2 | $1.5M | Buy |
+51,418
| New | +$1.24M | 0.02% | 675 |
|
|
2013
Q4 | – | Sell |
-16,237
| Closed | -$434K | – | 3081 |
|
|
2013
Q3 | $434K | Buy |
16,237
+2,234
| +16% | +$53.2K | 0.01% | 1825 |
|
|
2013
Q2 | $344K | Buy |
+14,003
| New | +$278K | 0.01% | 1763 |
|
Jane Street's PTLA Position: Q2 2020 in Review
Jane Street sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 96,746 shares — an estimated $1.35M sold.
Jane Street first reported a position in PTLA in Q2 2013 and held it in 20 quarters. The position peaked at $2.61M in Q2 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.
- Jane Street reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
- Jane Street sold 96,746 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1.35M.
- Jane Street first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
- Jane Street's Portola Pharmaceuticals, Inc. position peaked at $2.61M in Q2 2017.
- 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.
Based on Jane Street's 13F filing for Q2 2020, filed 17 Aug 2020.